Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039488511> ?p ?o ?g. }
- W3039488511 endingPage "1056" @default.
- W3039488511 startingPage "1043" @default.
- W3039488511 abstract "Abstract Recommendations were made recently to limit or stop the use of oral and systemic immunotherapies for skin diseases due to potential risks to the patients during the current severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) COVID‐19 pandemic. Herein, we attempt to identify potentially safe immunotherapies that may be used in the treatment of cutaneous diseases during the current COVID‐19 pandemic. We performed a literature review to approximate the risk of SARS‐CoV‐2 infection, including available data on the roles of relevant cytokines, cell subsets, and their mediators in eliciting an optimal immune response against respiratory viruses in murine gene deletion models and humans with congenital deficiencies were reviewed for viral infections risk and if possible coronaviruses specifically. Furthermore, reported risk of infections of biologic and non‐biologic therapeutics for skin diseases from clinical trials and drug data registries were evaluated. Many of the immunotherapies used in dermatology have data to support their safe use during the COVID‐19 pandemic including the biologics that target IgE, IL‐4/13, TNF‐α, IL‐17, IL‐12, and IL‐23. Furthermore, we provide evidence to show that oral immunosuppressive medications such as methotrexate and cyclosporine do not significantly increase the risk to patients. Most biologic and conventional immunotherapies, based on doses and indications in dermatology, do not appear to increase risk of viral susceptibility and are most likely safe for use during the COVID‐19 pandemic. The limitation of this study is availability of data on COVID‐19." @default.
- W3039488511 created "2020-07-10" @default.
- W3039488511 creator A5022950349 @default.
- W3039488511 creator A5039016580 @default.
- W3039488511 creator A5046835137 @default.
- W3039488511 creator A5072830288 @default.
- W3039488511 date "2020-07-03" @default.
- W3039488511 modified "2023-09-27" @default.
- W3039488511 title "Infection risk of dermatologic therapeutics during the COVID‐19 pandemic: an evidence‐based recalibration" @default.
- W3039488511 cites W1488772574 @default.
- W3039488511 cites W1493978345 @default.
- W3039488511 cites W1498853059 @default.
- W3039488511 cites W1514283619 @default.
- W3039488511 cites W1521666696 @default.
- W3039488511 cites W1558841808 @default.
- W3039488511 cites W1907505870 @default.
- W3039488511 cites W1919283206 @default.
- W3039488511 cites W1926061940 @default.
- W3039488511 cites W1955132430 @default.
- W3039488511 cites W1959946112 @default.
- W3039488511 cites W1965049677 @default.
- W3039488511 cites W1968715103 @default.
- W3039488511 cites W1973354423 @default.
- W3039488511 cites W1975347539 @default.
- W3039488511 cites W1975501001 @default.
- W3039488511 cites W1976499918 @default.
- W3039488511 cites W1976551703 @default.
- W3039488511 cites W1986888030 @default.
- W3039488511 cites W2006181104 @default.
- W3039488511 cites W2006779897 @default.
- W3039488511 cites W2007386646 @default.
- W3039488511 cites W2012569032 @default.
- W3039488511 cites W2016286557 @default.
- W3039488511 cites W2024540441 @default.
- W3039488511 cites W2024644107 @default.
- W3039488511 cites W2026433621 @default.
- W3039488511 cites W2029473819 @default.
- W3039488511 cites W2032725983 @default.
- W3039488511 cites W2034453891 @default.
- W3039488511 cites W2047729613 @default.
- W3039488511 cites W2048141239 @default.
- W3039488511 cites W2063627867 @default.
- W3039488511 cites W2064691439 @default.
- W3039488511 cites W2070463916 @default.
- W3039488511 cites W2074467386 @default.
- W3039488511 cites W2095294682 @default.
- W3039488511 cites W2096326560 @default.
- W3039488511 cites W2099430274 @default.
- W3039488511 cites W2103432436 @default.
- W3039488511 cites W2104459753 @default.
- W3039488511 cites W2104613102 @default.
- W3039488511 cites W2106538501 @default.
- W3039488511 cites W2113774808 @default.
- W3039488511 cites W2114043064 @default.
- W3039488511 cites W2116956799 @default.
- W3039488511 cites W2121663010 @default.
- W3039488511 cites W2122048821 @default.
- W3039488511 cites W2122641956 @default.
- W3039488511 cites W2128173849 @default.
- W3039488511 cites W2128359149 @default.
- W3039488511 cites W2130316168 @default.
- W3039488511 cites W2130835116 @default.
- W3039488511 cites W2131727392 @default.
- W3039488511 cites W2136628679 @default.
- W3039488511 cites W2136846143 @default.
- W3039488511 cites W2138976024 @default.
- W3039488511 cites W2140020442 @default.
- W3039488511 cites W2145200173 @default.
- W3039488511 cites W2145249112 @default.
- W3039488511 cites W2146843653 @default.
- W3039488511 cites W2147391287 @default.
- W3039488511 cites W2151546806 @default.
- W3039488511 cites W2155965505 @default.
- W3039488511 cites W2157158772 @default.
- W3039488511 cites W2159064415 @default.
- W3039488511 cites W2159587574 @default.
- W3039488511 cites W2164576684 @default.
- W3039488511 cites W2169491330 @default.
- W3039488511 cites W2171889601 @default.
- W3039488511 cites W2172257129 @default.
- W3039488511 cites W2326643498 @default.
- W3039488511 cites W2337591460 @default.
- W3039488511 cites W2427767676 @default.
- W3039488511 cites W2512145851 @default.
- W3039488511 cites W2521108778 @default.
- W3039488511 cites W2522653422 @default.
- W3039488511 cites W2524008969 @default.
- W3039488511 cites W2552494309 @default.
- W3039488511 cites W2560774983 @default.
- W3039488511 cites W2565351134 @default.
- W3039488511 cites W2566019736 @default.
- W3039488511 cites W2570140560 @default.
- W3039488511 cites W2580341857 @default.
- W3039488511 cites W2602517913 @default.
- W3039488511 cites W2766291043 @default.
- W3039488511 cites W2767805413 @default.
- W3039488511 cites W2772776690 @default.
- W3039488511 cites W2775246129 @default.